All products are intended for in vitro research in licensed laboratory environments only
While we always personalize treatment, heres a general starting point we use when creating a plan: Dosage: 250 to 500 mcg per day Method: Subcutaneous injection near the affected joint Cycle: 4 weeks on, followed by 2 to 4 weeks off Duration: Usually 1 to 3 cycles, depending on severity Injectable BPC-157 is preferred for arthritis
Research demonstrates these effects prove particularly beneficial in ischemic or hypovascular tissues such as tendons and ligaments where limited blood supply typically impedes healing
They directly enhance your nervous system so you feel better and think clearly
In 2023, the FDA designated BPC-157 as a Category 2 bulk drug substance, meaning it cannot be compounded by commercial pharmaceutical companies, and there is insufficient evidence regarding potential harm to humans
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration, 2015